Beyond fiberI guess you were addressing the last couple of posts to me. For me, Bioneutra is a long term investment. Regarding evidence, the science is emerging. That entails both high risk and vast potential. Whether or not oligosaccharides can retain their designation as fiber might one of the less interesting possibilities.
Did you see the September article in the journal Nature re potential of oligosaccharides to optimize the gut biome to the extent that they may be a candidate treatment for Alzheimer’s disease? Perhaps there are other marketing opportunities beyond the word fiber.
Bioneutra, the company, is highly speculative. Yes, it might go under; then again, it might not. Time will tell.